Inas Aboobakar is an Ophthalmology physician affiliated with Broad Institute. OpenAlex indexes 42 publications with 616 citations (h-index 13).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
243 Charles St
Boston, MA 021143096
Telephone
617-573-3431Provider last certified this registry record 26 Aug 2022.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Glaukos CorporationProgram year20251 payment
- ABBVIE INC.Program year20241 payment
- Glaukos CorporationProgram year20232 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
89.7%Prostaglandin Analog35.4%Latanoprost87%Tafluprost5%Lumigan4%Travoprost4%Part D<11 patientsCarbonic Anhydrase Inhibitor22.2%Dorzolamide-Timolol73%Dorzolamide Hcl27%Part D<11 patients+ 5 more classes in this area
Cardiovascular
5.9%Beta blocker5.9%Timolol Maleate100%Part D<11 patientsAnti-infectives
2.1%Macrolide1.3%Erythromycin100%Part D<11 patientsFluoroquinolone Antibacterial0.8%Moxifloxacin100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2024–2026 per NIH RePORTER. The latest:
- Clinical and functional assessment of glaucoma-associated mitochondrial gene variants to facilitate precision eye care
Massachusetts Eye and Ear Infirmary
FY2026$269,782K23EY035734 - Clinical and functional assessment of glaucoma-associated mitochondrial gene variants to facilitate precision eye care
Massachusetts Eye and Ear Infirmary
FY2025$269,782K23EY035734 - Clinical and functional assessment of glaucoma-associated mitochondrial gene variants to facilitate precision eye care
Massachusetts Eye and Ear Infirmary
FY2024$269,782K23EY035734
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Amblyopia and adult health: a comprehensive analysis of long-term systemic, sensory and mental health comorbidities in a national cohort
British Journal of Ophthalmology
2026 - The Inter-Eye Differences of the Circumpapillary Microvasculature in Primary Open-Angle Glaucoma
Translational Vision Science & Technology
2026
Similar KOLs
Other experts from the same institution or the same specialty.
Alan Mullen, MD, PhD
Broad Institute
Benjamin Ebert, MD
Broad Institute
Susan Redline, MD
Broad Institute
Patrick Ellinor, MD, PhD
Broad Institute
Emily Chew, MD
National Eye Institute
Robert Weinreb, MD
University of California San Diego
Harry Quigley, MD
Johns Hopkins University School of Medicine
Joel Schuman, MD
Wills Eye Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”